N/A N=295 Screening

COVID-19 Testing and Vaccine Literacy for Women With Criminal Legal System Involvement

COVID-19 Pandemic

Bottom Line

View on ClinicalTrials.gov: NCT05582746 ↗

Enrolled (actual)

295

Serious AEs

—

Results posted

Jan 2025

Primary outcome: Primary: COVID-19 Testing and Vaccine Knowledge — 3.58; 3.98; 3.85 score on a scale

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Tri-City COVID Attitudes Study (Behavioral)
Age: Adult, Older Adult · 18+ yrs
Sex: Female
Sponsor: University of Kansas Medical Center
Primary completion: Oct 2024

Outcome Measures

Outcome	Result	p-value
PRIMARY COVID-19 Testing and Vaccine Knowledge	3.58; 3.98; 3.85	—
PRIMARY COVID-19 Mistrust Score	3.25; 3.09; 3.21	—
PRIMARY COVID-19 Testing Accessibility - Ease of Access	4.36; 4.51; 4.49	—
PRIMARY COVID-19 Testing Accessibility - Confidence to Locate	4.42; 4.54; 4.49	—
PRIMARY COVID-19 Testing Accessibility - Free Access	209; 221; 195	—
PRIMARY Ever Had COVID-19 Testing	264; 253; 229	—
PRIMARY Ever Received COVID-19 Vaccine	191; 182; 165	—

Summary

The objective of this research is to use a localized mHealth intervention to boost COVID-19 testing and vaccine literacy, access, and uptake among women with CLSI

Eligibility Criteria

Inclusion Criteria

currently enrolled in the Tri-City C.R.E.W. study (R01CA226838)

Exclusion Criteria

Unable to provide informed consent

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05582746). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.